PCM
WST icon

Penserra Capital Management’s West Pharmaceutical WST Stock Holding History

Penserra Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Hold
3
– – ﹤0.01% 1101
2026
Q1 		$0 Sell
3
-3
-50% -$746 ﹤0.01% 1192
2025
Q4 		$1K Hold
6
– – ﹤0.01% 1050
2025
Q3 		$1K Hold
6
– – ﹤0.01% 1015
2025
Q2 		$1K Sell
6
-885
-99% -$189K ﹤0.01% 1014
2025
Q1 		$199K Buy
891
+137
+18% +$37.8K ﹤0.01% 738
2024
Q4 		$245K Buy
754
+144
+24% +$45.3K ﹤0.01% 708
2024
Q3 		$182K Buy
610
+143
+31% +$43.8K ﹤0.01% 716
2024
Q2 		$154K Buy
467
+461
+7,683% +$163K ﹤0.01% 768
2024
Q1 		$2K Sell
6
-337
-98% -$125K ﹤0.01% 1166
2023
Q4 		$120K Sell
343
-71
-17% -$25.1K ﹤0.01% 871
2023
Q3 		$155K Sell
414
-68
-14% -$26.3K ﹤0.01% 809
2023
Q2 		$183K Buy
482
+478
+11,950% +$171K ﹤0.01% 816
2023
Q1 		$1K Hold
4
– – ﹤0.01% 1088
2022
Q4 		$0 Buy
+4
New +$948 ﹤0.01% 1239
2022
Q1 		– Sell
-17,964
Closed -$8.43M – 1503
2021
Q4 		$8.43M Buy
17,964
+11,466
+176% +$4.94M 0.18% 153
2021
Q3 		$2.76M Buy
+6,498
New +$2.74M 0.06% 306
2021
Q1 		– Sell
-8,144
Closed -$2.31M – 1150
2020
Q4 		$2.31M Sell
8,144
-16,938
-68% -$4.75M 0.05% 250
2020
Q3 		$6.89M Buy
25,082
+24,072
+2,383% +$6.37M 0.26% 100
2020
Q2 		$229K Sell
1,010
-530
-34% -$104K 0.01% 464
2020
Q1 		$308K Buy
+1,540
New +$237K 0.02% 397

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Penserra Capital Management's WST Position: Q2 2026 in Review

Penserra Capital Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 3 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1101.

Penserra Capital Management first reported a position in WST in Q1 2020 and has held it in 21 quarters since. The position peaked at $8.43M in Q4 2021. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Penserra Capital Management held 3 shares of West Pharmaceutical worth $1K as of Q2 2026.
  • Penserra Capital Management left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #1101 holding.
  • Penserra Capital Management first reported a position in West Pharmaceutical in Q1 2020 and has held it in 21 quarters since.
  • Penserra Capital Management's West Pharmaceutical position peaked at $8.43M in Q4 2021.
  • 833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.